A mutual information-based in vivo monitoring of adaptive response to targeted therapies in melanoma
The mechanisms of adaptive resistance to genetic-based targeted therapies of solid malignancies have been the subject of intense research. These studies hold great promise for finding co-targetable hub/pathways which in turn would control the downstream non-genetic mechanisms of adaptive resistance....
Main Authors: | Aurore Bugi-Marteyn, Fanny Noulet, Nicolas Liaudet, Rastine Merat |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558621000506 |
Similar Items
-
Exome sequencing of a colorectal cancer family reveals shared mutation pattern and predisposition circuitry along tumor pathways
by: Suleiman H Suleiman, et al.
Published: (2015-09-01) -
Molecular Targeting of HuR Oncoprotein Suppresses MITF and Induces Apoptosis in Melanoma Cells
by: Rebaz Ahmed, et al.
Published: (2021-01-01) -
The long non-coding RNA H19 suppresses carcinogenesis and chemoresistance in hepatocellular carcinoma
by: Christina S. Schultheiss, et al.
Published: (2017-08-01) -
HuR Protein in Hepatocellular Carcinoma: Implications in Development, Prognosis and Treatment
by: Vasiliki Papatheofani, et al.
Published: (2021-01-01) -
HuRdling Senescence: HuR Breaks BRAF-Induced Senescence in Melanocytes and Supports Melanoma Growth
by: Janika K. Liebig, et al.
Published: (2020-05-01)